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Plumbagin and its Cu (II) complex [Cu (plumbagin)2]·H2O have been synthesized, and their antioxidant activities towards the
inhibitory eﬀect on DPPH free radical, reducing power, total antioxidant capacity, and inhibition on lipid peroxidation were
investigated. Plumbagin and its Cu (II) complex were found to exhibit scavenging activities on DPPH radical with the inhibitory
rate of 41% and 24%, respectively. The reducing power of plumbagin was outstanding at the concentrations of 1.0, 1.5, and
2.0mg/mL, compared to Cu (II) complex and synthetic antioxidant 2,6-di-ter-butyl-4-methylphenol (BHT); the highest level
reached 1.333 for plumbagin and 0.581 for Cu (II) complex. Also, the inhibition on lipid peroxidation of plumbagin was higher
than that of Cu (II) complex and BHT, 46.4% for plumbagin and 24.5% for Cu (II) complex. The results give a strong impact for
designing anticancer drugs, combined with their potential cytotoxic and antioxidant activities, which can be targeted selectively
against cancer cells and increase their therapeutic index and additional advantages over other anticancer drugs.
1.Introduction
Recently, a large number of metal complexes have been
designedandtestedforanticanceractivityandforsupportive
therapy in cancer patients, including the anticancer drugs
doxorubicin, mitoxantrone, bleomycin, and hydroxyurea [1–
3]. There is a major debate at present that natural products
with diverse bioactivities are becoming an important source
ofpotential(pro)drugchelators[4,5].Manynaturallyoccur-
ring molecules such as ﬂavonoids, phenols, and quinones
have metal chelating properties, cytotoxic, and antioxidant
properties, including the inhibitory eﬀect on free radicals
and other damaging oxygen activated products such as the
hydroxyl radical, superoxide, hydrogen peroxide, and lipid
peroxides [6, 7]. Thus, the prospect of designing chelating
prodrugs can be targeted selectively and activated against
cancer cells combined with their potential cytotoxic and an-
tioxidant activities increasing their therapeutic index and
provides additional advantages over other anticancer drugs
[8–10].
Our earlier studies have reported the synthesis and an-
ticancer activities of plumbagin (Scheme 1) and its Cu (II)
complex (Scheme 2). Plumbagin structurally derived from
naphthoquinone was extracted from Plumbago zeylanica L, a
Chinese traditional medicine. It was found that both plum-
baginanditsCu(II)complexexhibitedsigniﬁcantantitumor
activities against seven human tumour cell lines (BEL-7404,
NCI-H460, CNE-2, 786-O, MCF-7, HCT-116, and Hep-
G2), and Cu (II) complex possessed signiﬁcantly enhanced
antitumor with respect to the free ligand Cu (II) ion plays an
important role [11]. All of these results make it interesting to
study the antioxidant activities of plumbagin and its Cu (II)
complex.
2.MaterialsandMethods
UV-Vis absorption spectra were performed on a Varian
Cary100UV-Visiblespectrophotometer.2,2 -Diphenyl-1-pi-
crylhydrazyl (DPPH) was purchased from Sigma Chemicals
Co. All the metallic salts were purchased from Alfa Co. Ltd.
T h es o l v e n t sw e r ea n a l y t i c a lg r a d e .A l lt h em a t e r i a l sw e r e
used as received without further puriﬁcation unless noted
speciﬁcally.
Plant material, roots of P. zeylanica,w a sc o l l e c t e di n
Guangxi province and identiﬁed by Prof. Tang (Institute of
Life Science, Guangxi Normal University).2 Bioinorganic Chemistry and Applications
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Scheme 1: Crystal structure of plumbagin.
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Scheme 2: Crystal structure of plumbagin Cu (II) complex.
2.1. Isolation and Structure Identiﬁcation of PLN. The roots
of P. zeylanica (15kg) were extracted with 95% EtOH. The
solvent was concentrated in vacuo, and the residue was suc-
cessively partitioned between H2O and n-hexane followed
by EtOAc. The EtOAc extract (252g) was subjected to silica
gel cc with a gradient of EtOAc in n-hexane, eluting with n-
hexane-EtOAc (9:1) to yield an orange crystal, plumbagin
(1.33g).
2.2. Synthesis of [Cu(Plumbagin)2]·H2O. This yellowish
brown of plumbagin Cu (II) complex was synthesized by the
same method as the reference described by Chen et al. [11].
2.3. Scavenging Activity on DPPH Radical. To evaluate the
free radical scavenging activity, plumbagin or Cu (II) com-
plex solution was allowed to react with a stable free rad-
ical, 2,2 -diphenyl-1-picrylhydrazyl radical (DPPH) [12].
1mg/mL of plumbagin or Cu (II) complex in diﬀerent
reaction times (10, 20, 30, 40, 50, and 60min) was assayed,
and 1mg/mL of synthetic antioxidant 2,6-di-ter-butyl-4-
methylphenol (BHT) used for comparison. The reaction
mixture was incubated at 25◦C. The scavenging activity on
DPPH radical was determined by measuring the absorbance
at 515nm each 10min until the reaction reached the steady
state. The antioxidant activity was expressed as a percentage
of scavenging activity on DPPH radical: SC% = [1 −
(absorbance of sample)/(absorbance of control)] × 100%.
2.4. Reducing Power. The determination of reducing power
was performed as described by Oyaizu [13]. The reducing
power of various plumbagin and Cu (II) complex solutions
(0.5,1.0,1.5,and2.0mg/mL)wasinvestigated; BHTwasalso
determinedforcomparison.Thevarioussamplesweremixed
with phosphate buﬀer (2.5mL, 0.2M, pH 6.6), potassium
ferricyanide (2.5mL, 1%) was incubated at 25◦C for 20min,
trichloroacetic acid was added, and the mixture was cen-
trifuged at 3000rpm for 10min. The upper layer of solution
(2.5mL) was mixed with distilled water (2.5mL) and ferric
chloride (0.5mL, 0.1%), then the absorbance was measured
at 695nm against a blank.
2.5. Determination of Total Antioxidant Capacity. The total
antioxidant capacity was determined according to the
method of Prieto [14]. Plumbagin or Cu (II) complex
(0.5mg/mL) in diﬀerent reaction times (20, 40, 60, 80,
100, and 120min) was combined with 0.3mL of reagent
solution (0.6M sulphuric acid, 28mM sodium phosphate,
and 4mM ammonium molybdate). The reaction mixture
was incubated at 95◦C for 150min. After the mixture had
been cooled to room temperature, the absorbance of the
mixture was measured at 595nm against a blank. The
readings were taken each 30min. The antioxidant activity of
BHT (0.5mg/mL) was also assayed for comparison.
2.6. Antioxidant Potential of Plumbagin or Cu (II) Complex
in Peanut Oil. Calculated amounts of plumbagin or Cu (II)
complex solution were added to 50mL of peanut oil. The
additive was mixed into the oil with a magnetic stirrer. The
oxidative deterioration of samples was studied using Schaal
oven test method as described by Economou et al. [15].
The oil samples (50mL each) were placed in open 100mL
beakers and placed in 60 ± 0.5◦C oven for 24h. The
sample (1mg/mL) was prepared under the same conditions
treated with diﬀerent reaction times (1, 2, 3, 4, 5, and 6
days), BHT (1mg/mL) was also assayed for comparison. The
rate of antioxidant of peanut oil was estimated according
to the increase of 2-thiobarbituric acid-reactive substances
(TBARS) using the classical TBA procedure. The TBARS val-
ues of untreated and treated samples were used to calculate
the inhibition of lipid oxidation as follows: Inhibition (%) =
(control-treatment)/control × 100%.
2.7.StatisticalAnalysis. Allexperimentalresultswerecentred
at using three parallel measurements of mean ± SD. Analysis
of variance was performed by ANOVA procedure. Duncan’s
new multiple-range test was used to determine the diﬀer-
ences of means. P values < 0.05 were regarded as signiﬁcant
and P values < 0.01 as very signiﬁcant.Bioinorganic Chemistry and Applications 3
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Figure 1: DPPH free radical scavenging activity of plumbagin, Cu
(II) complex, and BHT in diﬀerent reaction times (10, 20, 30, 40,
50, and 60min).
3. Results andDiscussion
3.1. Scavenging Activity on DPPH Radical. Antioxidant
properties, especially radical scavenging activities, are very
important due to the deleterious role of free radicals in
biological system. DPPH is a kind of stable free radical
a n da c c e p t sa ne l e c t r o no rh y d r o g e nr a d i c a lt ob e c o m ea
stable diamagnetic molecule [6], which was widely used to
investigate radical scavenging activity now for its advantage
of ease and economy. In DPPH radical scavenging assay,
antioxidants are able to reduce the stable DPPH radical to
yellow-coloured, and the antioxidant power is indicated by
the degree of discoloration which could be determined by
measuring of a decrease in the absorbance at 515nm.
As Figure 1 shows, at the concentration of 1mg/mL of
plumbagin or Cu (II) complex possessed scavenging activ-
ities on DPPH radical with the inhibitory rate of 41% and
24%, respectively, their scavenging eﬀect increased with
increasing reaction time, and plumbagin scavenging activ-
ities are pretty, more higher than its Cu (II) complex and
BHT, indicating that the presence of Cu (II) decreased the
scavenging eﬀect of DPPH radical.
3.2. Reducing Power. The reducing capacity of a compound
may serve as a signiﬁcant indicator of its potential antiox-
idant activity [16]. In the assay, the presence of reductants
in the antioxidant sample causes the reduction of the
Fe3+/ferricyanide complex to the Fe2+/ferrous form [17], so
the reducing power of the sample could be monitored by
measuring the formation of Perl’s Prussian blue at 695 nm
[18]. As Figure 2 shows, the reducing properties of plumba-
gin and Cu (II) complex at diﬀerent concentration exhibited
correlation with increasing concentration. The reducing
power of plumbagin was outstanding at the concentration of
1.5 and 2.0mg/mL compared to Cu (II) complex and BHT.
At the concentration of 2.0mg/mL, the reducing power of
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Figure 2: The reducing power of plumbagin, Cu (II) complex and
BHT treated with diﬀerent solution concentrations (0.5, 1.0, 1.5,
and 2.0mg/mL).
plumbagin and Cu (II) complex reached 1.333 and 0.581,
respectively. It was speculated that the decreased antioxidant
power of Cu (II) complex, compared to plumbagin, may be
the absence of phenolic group due to forming the complex,
thusthepresenceoftheactivehydrogeninphenolichydroxyl
group was likely to contribute considerably to the observed
antioxidant eﬀects.
3.3. Total Antioxidant Capacity Assay. T h ea s s a yi sb a s e do n
the reduction of Mo (VI) to Mo (V) by plumbagin and
Cu (II) complex in diﬀerent reaction times (20, 40, 60, 80,
100, and 120min) and subsequent formation of a green
phosphate/Mo (V) complex at acid pH. The high absorbance
values indicated that the sample possessed signiﬁcant antiox-
idant activity. As Figure 3 shows, plumbagin and Cu (II)
had signiﬁcant total antioxidant activities compared to BHT,
and the eﬀects increased with increasing reaction time, while
total antioxidant capacity of Cu (II) complex was superior to
plumbagin.
3.4. Lipid Peroxidation in Peanut Oil. The level of 2-thi-
obarbituric acid-reactive substances (TBARS), products of
lipid peroxidation, is often measured in order to assess the
extent of oxidation that occurs in biological systems. Peanut
oil was treated with plumbagin, Cu (II), and BHT complex
at the concentration of 1mg/mL in diﬀerent reaction times
( 1 ,2 ,3 ,4 ,5 ,a n d6d a y s ) .A ss h o w ni nF i g u r e4, the
inhibition rate of lipid oxidation between plumbagin and Cu
(II) complex had signiﬁcant eﬀects and was enhanced with
increasing reaction time, the highest level reached 46.4% for
plumbagin and 24.5% for Cu (II) complex after 6 days, and
the lipid oxidation inhibition of Cu (II) complex is lower
than that of PLN and BHT at the same period.4 Bioinorganic Chemistry and Applications
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Figure 3: The total antioxidant power of plumbagin, Cu (II) com-
plex, and BHT in diﬀerent reaction times (20, 40, 60, 80, 100, and
120min).
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Figure 4: Lipid oxidation inhibition by plumbagin, Cu (II) com-
plex, and BHT in peanut oil in diﬀe r e n tr e a c t i o nt i m e s( 1 ,2 ,3 ,4 ,5 ,
and 6 days).
4. Conclusions
In this study, we have investigated the antioxidant possibility
of plumbagin and its Cu (II) complex. The results indicated
that both the compounds exhibited some antioxidant activ-
ities, including the inhibitory eﬀect on DPPH free radical,
reducing power, total antioxidant capacity, and lipid peroxi-
dation, which plumbagin possessed higher abilities than that
of Cu (II) complex and BHT at the same condition towards
DPPH free radical, reducing power, and lipid peroxidation.
It was speculated that the decreased antioxidant power
of Cu (II) complex compared to plumbagin may be the
absence of phenolic group due to forming the complex, thus
the presence of the active hydrogen in phenolic hydroxyl
group was likely to contribute considerably to the observed
antioxidant eﬀects. Also, this study gives a strong impact for
designing anticancer drugs, combined with their potential
cytotoxic and antioxidant activities, which can be targeted
selectively against cancer cells and increase their therapeutic
index and additional advantages overother anticancerdrugs.
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